why would Amgen breakout here? Well, maybe it won't, and the goons pumping it on national television are taking the other side as it approaches a perennial resistance ceiling...or maybe the assumption of it's inclusion in the XLV weighted at 3.4% is enough for fund flows to push it over $260.
With COVID raging in the prior December quarter, they could miss on earnings, and give strong guidance going forward, but at 21x, looks baked in. And this thing could get swept up in a market decline.
With COVID raging in the prior December quarter, they could miss on earnings, and give strong guidance going forward, but at 21x, looks baked in. And this thing could get swept up in a market decline.
Komentar:
call made 🤙🏽. too bad it's a $250 stock would've scooped up some put contracts against this garbage call over a week ago. There's some real two bit hustlers pumping questionable shit on CNBC.